Literature DB >> 12598211

Nosology for our day: its application to chronic obstructive pulmonary disease.

Gordon L Snider1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12598211     DOI： 10.1164/rccm.200203-204PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

1.  MicroRNA-338-5p modulates pulmonary hypertension-like injuries caused by SO2, NO2 and PM2.5 co-exposure through targeting the HIF-1α/Fhl-1 pathway.

Authors:  Xiaotong Ji; Yingying Zhang; Tingting Ku; Yang Yun; Guangke Li; Nan Sang
Journal:  Toxicol Res (Camb)       Date:  2016-09-09       Impact factor: 3.524

2.  Clinical and Radiologic Disease in Smokers With Normal Spirometry.

Authors:  Elizabeth A Regan; David A Lynch; Douglas Curran-Everett; Jeffrey L Curtis; John H M Austin; Philippe A Grenier; Hans-Ulrich Kauczor; William C Bailey; Dawn L DeMeo; Richard H Casaburi; Paul Friedman; Edwin J R Van Beek; John E Hokanson; Russell P Bowler; Terri H Beaty; George R Washko; MeiLan K Han; Victor Kim; Song Soo Kim; Kunihiro Yagihashi; Lacey Washington; Charlene E McEvoy; Clint Tanner; David M Mannino; Barry J Make; Edwin K Silverman; James D Crapo
Journal:  JAMA Intern Med       Date:  2015-09       Impact factor: 21.873

3.  Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?

Authors:  David M Mannino; A Sonia Buist; William M Vollmer
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

Review 4.  Developing new drug treatments in the era of network medicine.

Authors:  E K Silverman; J Loscalzo
Journal:  Clin Pharmacol Ther       Date:  2012-10-15       Impact factor: 6.875

5.  An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages.

Authors:  R de Marco; S Accordini; I Cerveri; A Corsico; J Sunyer; F Neukirch; N Künzli; B Leynaert; C Janson; T Gislason; P Vermeire; C Svanes; J M Anto; P Burney
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

6.  The nature and causes of chronic obstructive pulmonary disease: a historical perspective. The Christie Lecture 2007, Chicago, USA.

Authors:  C Peter W Warren
Journal:  Can Respir J       Date:  2009 Jan-Feb       Impact factor: 2.409

7.  COPD prevalence in a random population survey: a matter of definition.

Authors:  P Shirtcliffe; M Weatherall; S Marsh; J Travers; A Hansell; A McNaughton; S Aldington; H Muellerova; R Beasley
Journal:  Eur Respir J       Date:  2007-08       Impact factor: 16.671

8.  Lung function decline and outcomes in an elderly population.

Authors:  D M Mannino; K J Davis
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

9.  Transcriptional profiling and targeted proteomics reveals common molecular changes associated with cigarette smoke-induced lung emphysema development in five susceptible mouse strains.

Authors:  Maciej Cabanski; Brett Fields; Stephanie Boue; Natalia Boukharov; Hector DeLeon; Natalie Dror; Marcel Geertz; Emmanuel Guedj; Anita Iskandar; Ulrike Kogel; Celine Merg; Michael J Peck; Carine Poussin; Walter K Schlage; Marja Talikka; Nikolai V Ivanov; Julia Hoeng; Manuel C Peitsch
Journal:  Inflamm Res       Date:  2015-05-12       Impact factor: 4.575

10.  Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria.

Authors:  Yong Il Hwang; Chang Hwan Kim; Hye-Ryun Kang; Taerim Shin; Sang Myeon Park; Seung Hun Jang; Yong Bum Park; Cheol Hong Kim; Dong-Gyu Kim; Myung Goo Lee; In-Gyu Hyun; Ki-Suck Jung
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.